$3.44 Billion is the total value of Rock Springs Capital Management LP's 131 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 10.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HUM | Buy | HUMANA INC | $199,565,000 | +24.4% | 426,358 | +15.7% | 5.81% | +43.8% |
| AGL | Buy | AGILON HEALTH INC | $167,676,000 | -13.4% | 7,681,000 | +0.5% | 4.88% | +0.1% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $137,910,000 | +12.7% | 268,500 | +11.9% | 4.01% | +30.3% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $109,421,000 | +5.6% | 1,122,500 | +1.6% | 3.18% | +22.1% |
| PODD | Buy | INSULET CORP | $109,406,000 | -14.7% | 502,000 | +4.2% | 3.18% | -1.4% |
| IMCR | Buy | IMMUNOCORE HLDGS PLCads | $99,679,000 | +30.6% | 2,671,652 | +4.7% | 2.90% | +51.0% |
| EVH | Buy | EVOLENT HEALTH INCcl a | $84,084,000 | +9.4% | 2,738,000 | +15.0% | 2.45% | +26.5% |
| ALGN | Buy | ALIGN TECHNOLOGY INC | $83,900,000 | -11.1% | 354,500 | +63.7% | 2.44% | +2.8% |
| IDXX | Buy | IDEXX LABS INC | $78,476,000 | -34.4% | 223,750 | +2.3% | 2.28% | -24.2% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $65,210,000 | -12.7% | 1,093,030 | +6.3% | 1.90% | +1.0% |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $64,924,000 | -16.3% | 2,928,458 | +9.9% | 1.89% | -3.3% |
| PCRX | Buy | PACIRA BIOSCIENCES INC | $59,320,000 | -22.3% | 1,017,500 | +1.8% | 1.73% | -10.2% |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $57,244,000 | -18.5% | 602,000 | +0.9% | 1.67% | -5.8% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $56,723,000 | +23.3% | 844,977 | +51.0% | 1.65% | +42.6% |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $55,904,000 | +1.9% | 441,893 | +2.2% | 1.63% | +17.8% |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $54,823,000 | -17.7% | 3,927,149 | +1.6% | 1.60% | -4.8% |
| PEN | Buy | PENUMBRA INC | $49,995,000 | +10.1% | 401,500 | +96.3% | 1.46% | +27.3% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $49,458,000 | -18.3% | 979,174 | +3.3% | 1.44% | -5.6% |
| SGEN | Buy | SEAGEN INC | $48,128,000 | +23.5% | 272,000 | +0.6% | 1.40% | +42.8% |
| CERE | Buy | CEREVEL THERAPEUTICS HLDNG I | $46,723,000 | -22.6% | 1,767,141 | +2.5% | 1.36% | -10.5% |
| ZLAB | Buy | ZAI LAB LTDadr | $42,167,000 | -20.5% | 1,215,900 | +0.8% | 1.23% | -8.1% |
| ASND | Buy | ASCENDIS PHARMA A/Ssponsored adr | $39,554,000 | -19.3% | 425,500 | +1.9% | 1.15% | -6.7% |
| DXCM | Buy | DEXCOM INC | $35,238,000 | -33.8% | 472,800 | +354.6% | 1.03% | -23.4% |
| CVET | Buy | COVETRUS INC | $34,835,000 | +23.9% | 1,678,800 | +0.2% | 1.01% | +43.2% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $34,180,000 | +32.7% | 1,123,604 | +33.4% | 1.00% | +53.5% |
| NVRO | Buy | NEVRO CORP | $33,894,000 | -35.1% | 773,300 | +7.2% | 0.99% | -25.0% |
| WST | Buy | WEST PHARMACEUTICAL SVSC INC | $33,563,000 | +18.0% | 111,000 | +60.3% | 0.98% | +36.5% |
| MIRM | Buy | MIRUM PHARMACEUTICALS INC | $33,427,000 | -8.9% | 1,717,733 | +3.1% | 0.97% | +5.3% |
| FRPT | Buy | FRESHPET INC | $33,085,000 | -45.6% | 637,600 | +7.6% | 0.96% | -37.1% |
| PHR | Buy | PHREESIA INC | $32,468,000 | +29.7% | 1,298,200 | +36.7% | 0.94% | +50.0% |
| XLV | New | SELECT SECTOR SPDR TRsbi healthcare | $25,648,000 | – | 200,000 | +100.0% | 0.75% | – |
| NVAX | Buy | NOVAVAX INC | $24,434,000 | -26.0% | 475,100 | +6.0% | 0.71% | -14.4% |
| ABCM | Buy | ABCAM PLCads | $23,432,000 | -10.6% | 1,620,500 | +13.1% | 0.68% | +3.3% |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $22,726,000 | -15.3% | 317,485 | +16.1% | 0.66% | -2.2% |
| EXAS | Buy | EXACT SCIENCES CORP | $22,559,000 | -43.4% | 572,700 | +0.5% | 0.66% | -34.5% |
| CNMD | Buy | CONMED CORP | $21,354,000 | -29.0% | 223,000 | +10.1% | 0.62% | -18.0% |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $21,170,000 | +22.8% | 1,681,458 | +5.7% | 0.62% | +41.9% |
| TPTX | New | TURNING POINT THERAPEUTICS I | $20,452,000 | – | 271,787 | +100.0% | 0.60% | – |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $18,831,000 | +25.7% | 4,075,958 | +8.5% | 0.55% | +45.4% |
| OLK | Buy | OLINK HLDG ABsponsored ads | $18,723,000 | +7.5% | 1,231,800 | +24.9% | 0.54% | +24.4% |
| PRTA | Buy | PROTHENA CORP PLC | $18,420,000 | -24.1% | 678,462 | +2.3% | 0.54% | -12.3% |
| RXDX | Buy | PROMETHEUS BIOSCIENCES INC | $18,194,000 | -22.8% | 644,507 | +3.2% | 0.53% | -10.8% |
| ACCD | Buy | ACCOLADE INC | $16,280,000 | -38.4% | 2,200,000 | +46.2% | 0.47% | -28.7% |
| CYTK | New | CYTOKINETICS INC | $15,716,000 | – | 400,000 | +100.0% | 0.46% | – |
| BCRX | New | BIOCRYST PHARMACEUTICALS INC | $15,458,000 | – | 1,461,091 | +100.0% | 0.45% | – |
| KYMR | Buy | KYMERA THERAPEUTICS INC | $15,277,000 | -52.2% | 775,879 | +2.6% | 0.44% | -44.7% |
| Buy | WARBY PARKER INC | $14,340,000 | -59.2% | 1,273,500 | +22.6% | 0.42% | -52.8% | |
| Buy | AURA BIOSCIENCES INC | $14,295,000 | -35.5% | 1,008,814 | +0.1% | 0.42% | -25.4% | |
| HCAT | Buy | HEALTH CATALYST INC | $13,699,000 | -42.6% | 945,400 | +3.5% | 0.40% | -33.6% |
| INZY | Buy | INOZYME PHARMA INC | $12,593,000 | +158.1% | 2,640,056 | +121.3% | 0.37% | +197.6% |
| BRKS | New | AZENTA INC | $11,680,000 | – | 162,000 | +100.0% | 0.34% | – |
| ANAB | Buy | ANAPTYSBIO INC | $11,618,000 | -16.6% | 572,300 | +1.6% | 0.34% | -3.7% |
| EPZM | Buy | EPIZYME INC | $11,004,000 | +31.7% | 7,485,543 | +3.0% | 0.32% | +52.4% |
| RLAY | Buy | RELAY THERAPEUTICS INC | $10,356,000 | -42.5% | 618,267 | +2.8% | 0.30% | -33.6% |
| IMTX | New | IMMATICS N.V | $9,825,000 | – | 1,127,970 | +100.0% | 0.29% | – |
| AMYT | Buy | AMRYT PHARMA PLCsponsored ads | $9,175,000 | -15.0% | 1,312,625 | +0.5% | 0.27% | -1.8% |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $9,044,000 | +172.8% | 335,477 | +244.7% | 0.26% | +216.9% |
| NVTA | Buy | INVITAE CORP | $8,527,000 | -67.8% | 3,494,721 | +5.1% | 0.25% | -62.8% |
| AUPH | Buy | AURINIA PHARMACEUTICALS INC | $8,192,000 | -14.2% | 815,126 | +5.7% | 0.24% | -0.8% |
| KNTE | Buy | KINNATE BIOPHARMA INC | $7,798,000 | +101.2% | 618,384 | +79.7% | 0.23% | +131.6% |
| NKTX | Buy | NKARTA INC | $7,593,000 | +30.8% | 616,277 | +20.9% | 0.22% | +51.4% |
| MREO | Buy | MEREO BIOPHARMA GROUP PLCads | $6,978,000 | +2.6% | 6,230,275 | +2.6% | 0.20% | +18.7% |
| DSGN | Buy | DESIGN THERAPEUTICS INC | $6,445,000 | +15.5% | 460,391 | +33.2% | 0.19% | +34.3% |
| AKRO | Buy | AKERO THERAPEUTICS INC | $6,421,000 | -28.8% | 679,514 | +7.0% | 0.19% | -17.6% |
| EDAP | Buy | EDAP TMS S Asponsored adr | $6,188,000 | +4.1% | 910,000 | +11.0% | 0.18% | +20.0% |
| RYTM | Buy | RHYTHM PHARMACEUTICALS INC | $5,824,000 | -59.1% | 1,403,298 | +13.4% | 0.17% | -52.9% |
| BEAM | New | BEAM THERAPEUTICS INC | $4,313,000 | – | 111,430 | +100.0% | 0.13% | – |
| LPTX | Buy | LEAP THERAPEUTICS INC | $4,201,000 | -33.2% | 3,652,947 | +1.6% | 0.12% | -22.8% |
| ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $4,008,000 | -15.3% | 2,357,544 | +2.6% | 0.12% | -1.7% |
| Buy | XILIO THERAPEUTICS INC | $3,980,000 | -52.7% | 1,362,878 | +14.4% | 0.12% | -45.3% | |
| GMDA | Buy | GAMIDA CELL LTD | $3,850,000 | -56.9% | 2,175,000 | +1.0% | 0.11% | -50.2% |
| PRTK | Buy | PARATEK PHARMACEUTICALS INC | $3,347,000 | -34.7% | 1,734,037 | +0.4% | 0.10% | -24.8% |
| MGNX | Buy | MACROGENICS INC | $2,816,000 | -65.7% | 954,728 | +2.4% | 0.08% | -60.4% |
| PHAS | Buy | PHASEBIO PHARMACEUTICALS INC | $1,665,000 | -51.7% | 2,774,869 | +6.2% | 0.05% | -44.8% |
| AGLE | Buy | AEGLEA BIOTHERAPEUTICS INC | $1,552,000 | -62.7% | 3,072,034 | +69.6% | 0.04% | -57.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTUITIVE SURGICAL INC | 40 | Q3 2023 | 3.4% |
| NEUROCRINE BIOSCIENCES INC | 39 | Q3 2023 | 4.8% |
| PACIRA PHARMACEUTICALS INC | 39 | Q3 2023 | 2.6% |
| ULTRAGENYX PHARMACEUTICAL IN | 39 | Q3 2023 | 1.9% |
| ACADIA HEALTHCARE COMPANY IN | 38 | Q3 2023 | 4.4% |
| ASCENDIS PHARMA A/S | 35 | Q3 2023 | 1.3% |
| INVITAE CORP | 35 | Q3 2023 | 1.8% |
| BIOMARIN PHARMACEUTICAL INC | 35 | Q3 2023 | 1.3% |
| MACROGENICS INC | 35 | Q3 2023 | 0.5% |
| COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.1% |
View Rock Springs Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 3,413,906 | 5.6% |
| Compass Therapeutics, Inc. | February 14, 2023 | 5,333,188 | 4.2% |
| Mirum Pharmaceuticals, Inc. | February 14, 2023 | 1,795,733 | 4.9% |
| PhaseBio Pharmaceuticals IncSold out | February 14, 2023 | 0 | 0.0% |
| Sierra Oncology, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ARDELYX, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| CHIASMA, INCSold out | February 15, 2022 | 0 | 0.0% |
| FIVE PRIME THERAPEUTICS, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| F-star Therapeutics, Inc. | February 15, 2022 | 751,889 | 3.6% |
| Protara Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
View Rock Springs Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-05-01 |
| SC 13G/A | 2024-04-05 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Rock Springs Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.